MS is a progressive disorder in which demyelination, axonal degeneration, and inflammation contribute to disease pathogenesis. ADEM is classically an acute, monophasic demyelinating disease in which axonal damage is present but minimal. About 20 percent of ADEM cases can have relapses and are diagnosed with MS later, posing a diagnostic dilemma at initial presentation. In this study, we investigate the role of directional diffusivity DTI as a MR biomarker to differentiate and predict Acute Disseminated Encephalomyelitis (ADEM) from Multiple Sclerosis (MS) in pediatric patients.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords